Pivot Pharma Enhances Executive Leadership, Onboards Russell Starr as Its President
Separator

Pivot Pharma Enhances Executive Leadership, Onboards Russell Starr as Its President

Separator
Pivot Pharma Enhances Executive Leadership, Onboards Russell Starr as Its President

CEO Insights Team

Pivot Pharmaceuticals, a pharmaceutical and nutraceutical company, welcomes Russell Starr as its new President. Russell will also take charge as interim Chief Executive Officer replacing Pivot’s prior CEO Patrick Frankham.

Excited over his new position, Russell proclaims, “This is an incredible opportunity, I am energized and honored to be a part of shaping the future of consumer focused cannabis products using Pivot's innovative, patent-protected drug delivery technologies to provide consumers with the consistent science-based quality they are demanding while generating substantial cash flow generation for Pivot and its shareholders.”

Russell will work in association with Krisztian Toth, the Executive Chairman of Pivot, and will be reporting to the Board of Directors. He will lead Pivot’s capital market activities which includes outreach to existing and potential shareholders in Canada and across the globe. This appointment will increase the company’s exposure among the institutional and retail investors. Russell possesses in depth management expertise in corporate finance and mergers & acquisitions.

Being a successful entrepreneur, and possessing more than 20 years of experience in corporate finance, investment and business development, Russell quit Bay Street in 2012(acquired by Agnico Eagle in 2014), and took up an executive position
and board appointments with Cayden Resources. Serving as Senior Vice President and board member of Cayden Resources, Russell played an integral role in marketing, financing, and contributed for the development & ultimate sale of cayden for CAD$ 205 million to Agnico Eagle.

Previously, Russell has also held several senior positions and advisory roles at financial institution which includes RBC Capital Markets, Scotia Capital, Orion Securities, Blackmont, and Lawrence & Company. He is also a Co-Founder of Echelon Wealth Partners, a Canadian investment dealer.

This is an incredible opportunity, I am energized and honored to be a part of shaping the future of consumer focused cannabis products using Pivot's innovative



Russell has earned an MBA from the Richard Ivey School of Business, a Master of Arts degree in Economics from the University of Victoria and a Bachelor of Arts degree in Economics from Queens University.

Commenting on the appointment, Krisztian states, “I am thrilled to add Russell to our team; he brings a unique combination of deep capital market experience and well-honed strategic and business capability. The closing of our transformational financing, the addition of elite branding experts like Joe Mimran to our Corporate Advisory Board and the additions to our Executive Leadership Team as well as our Board of Directors demonstrates our commitment to scale the company as we take work to become the first cannabis company to provide consumers with a consistent, reliable and quality experience.”